Cargando…

Why proteomics is not the new genomics and the future of mass spectrometry in cell biology

Mass spectrometry (MS) is an essential part of the cell biologist’s proteomics toolkit, allowing analyses at molecular and system-wide scales. However, proteomics still lag behind genomics in popularity and ease of use. We discuss key differences between MS-based -omics and other booming -omics tech...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidoli, Simone, Kulej, Katarzyna, Garcia, Benjamin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223617/
https://www.ncbi.nlm.nih.gov/pubmed/27956468
http://dx.doi.org/10.1083/jcb.201612010
_version_ 1782493204997734400
author Sidoli, Simone
Kulej, Katarzyna
Garcia, Benjamin A.
author_facet Sidoli, Simone
Kulej, Katarzyna
Garcia, Benjamin A.
author_sort Sidoli, Simone
collection PubMed
description Mass spectrometry (MS) is an essential part of the cell biologist’s proteomics toolkit, allowing analyses at molecular and system-wide scales. However, proteomics still lag behind genomics in popularity and ease of use. We discuss key differences between MS-based -omics and other booming -omics technologies and highlight what we view as the future of MS and its role in our increasingly deep understanding of cell biology.
format Online
Article
Text
id pubmed-5223617
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-52236172017-07-02 Why proteomics is not the new genomics and the future of mass spectrometry in cell biology Sidoli, Simone Kulej, Katarzyna Garcia, Benjamin A. J Cell Biol Commentary Mass spectrometry (MS) is an essential part of the cell biologist’s proteomics toolkit, allowing analyses at molecular and system-wide scales. However, proteomics still lag behind genomics in popularity and ease of use. We discuss key differences between MS-based -omics and other booming -omics technologies and highlight what we view as the future of MS and its role in our increasingly deep understanding of cell biology. The Rockefeller University Press 2017-01-02 /pmc/articles/PMC5223617/ /pubmed/27956468 http://dx.doi.org/10.1083/jcb.201612010 Text en © 2017 Sidoli et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Commentary
Sidoli, Simone
Kulej, Katarzyna
Garcia, Benjamin A.
Why proteomics is not the new genomics and the future of mass spectrometry in cell biology
title Why proteomics is not the new genomics and the future of mass spectrometry in cell biology
title_full Why proteomics is not the new genomics and the future of mass spectrometry in cell biology
title_fullStr Why proteomics is not the new genomics and the future of mass spectrometry in cell biology
title_full_unstemmed Why proteomics is not the new genomics and the future of mass spectrometry in cell biology
title_short Why proteomics is not the new genomics and the future of mass spectrometry in cell biology
title_sort why proteomics is not the new genomics and the future of mass spectrometry in cell biology
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223617/
https://www.ncbi.nlm.nih.gov/pubmed/27956468
http://dx.doi.org/10.1083/jcb.201612010
work_keys_str_mv AT sidolisimone whyproteomicsisnotthenewgenomicsandthefutureofmassspectrometryincellbiology
AT kulejkatarzyna whyproteomicsisnotthenewgenomicsandthefutureofmassspectrometryincellbiology
AT garciabenjamina whyproteomicsisnotthenewgenomicsandthefutureofmassspectrometryincellbiology